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Humans possess 25 selenoproteins, approximately half of which are enzymes (selenoenzymes) required for preventing, 
regulating, or reversing oxidative damage, while others participate in providing calcium metabolism, thyroid hormone 
maintenance, protein synthesis, cytoskeletal structure etc. This review examines the latest evidences of the biological effects of 
selenoproteins according to the method of complex analysis of the material. Selenoprotein P promotes insulin resistance in type 2 
diabetes, mediates myocardial ischemic-reperfusion injuries and provides protection against disease by reducing chronic oxidative 
stress. Selenoprotein T is expressed at the endoplasmic reticulum membrane in all cells during development, but is confined to 
endocrine tissues in adulthood, controls homeostasis of glucose and prevents neurodegeneration by reducing oxidative stress 
factors. Expression of selenoprotein K is required for efficient Ca2+ flux into melanoma cancer cells, tumour growth and 
metastasic potential depend on SelK but it suppresses human choriocarcinoma cells. SelK also serves to maintain the normal 
physiological functions of skeletal muscle. Selenoprotein N deficiency, caused by mutations in the human gene, promotes 
myopathy characterized by muscle weakness, spinal rigidity, respiratory insufficiency. Sel N participates in normal physiology of 
skeletal and smooth muscle tissues. Selenoprotein M is located in the endoplasmic reticulum, characterized by high expression in 
the brain, antioxidative, neuroprotective activity and regulates intracellular Ca2+ levels. Also, the overexpression of SelM was 
detected in human hepatocellular carcinoma. Selenoprotein S is mentioned as a regulator of ER stress and inflammatory 
processes. Selenoprotein F controls cell proliferation by the impact on G1period of the cell cycle. Moreover, it is implicated in the 
pathogenesis of some types of cancer. The Sel F deficiency reduces the migration and invasive ability of the cells. Knockdown of 
selenoprotein W in rodents leads to increased release of Ca2+, causes oxidative ultramicroscopic injuries of the endoplasmic 
reticulum and mitochondria ultrastructure, which in turn increases the levels of inflammatory factors. Selenoprotein H is involved 
in redox regulation, in tumourogenesis. Knockdown of selenoprotein H decreases cellular differentiation and increases 
proliferation and migration of cells. Selenoproteins U, V, I, O, R are recently identified and their functions are not clearly known. 
The data analyzed in the review help determine promising directions in the study of the selenoproteins.  
Keywords: selenium; expression of selenoproteins; functions of selenoproteins; antioxidants; deficiency of selenoproteins  
Introduction  
 
Implementation of the influence of the microelement selenium on 
biological systems is mediated by the inclusion of this element to the 
aminoacid residue of selenocysteine, which is an integral part of all 
selenoproteins. About 25 types of selenoproteins are known today, most 
of them are regulators of oxidative processes (Addinsall et al., 2018) 
and redox homeostasis (Wrobel et al., 2016). High metabolic activity of 
selenoproteins, their participation in the pathogenetic links of processes 
such as oxidative stress (Zachara, 2015; Kim et al., 2017), carcinogene-
sis (Guerriero et al., 2014; Short & Williams, 2017; Bertz et al., 2018), 
neurodegeneration (Pitts et al., 2014; Burk et al., 2014; Boukhzar et al., 
2016), insulin resistance (Prevost et al., 2013; Mita et al., 2017), myopathy 
(Moghadaszadeh et al., 2013), and others underscores the constant interest 
of the scientific community in the issues of the disclosure of mecha-
nisms for the realization all biological functions of these compounds. 
(Brigelius-Flohé, 2015). In addition to the generally known glutathione 
peroxidase, which performs the catalytic function in the reduction of 
hydroperoxides and lipoperoxids, other selenoproteins have been parti-
ally investigated. Thioredoxin reductase is one of them, it exists in three 
forms TrxR1, TrxR2, TGR (cytosolic, mitochondrial, and in the testic-
les, respectively). The thioredoxin system is extremely important for 
mammals, as evidenced by the early embryonic mortality of mice that 
lacked any of the isoforms (Bobba et al., 2014). Another enzyme inclu-
ding selenocysteine residue, iodothyronine deiodinase, plays an important 
role in the activation and inactivation of thyroid hormones (Hernandez 
& Stohn, 2018). Selenophosphate synthetase is a mammalian selenium 
enzyme that provides a synthesis of other selenogenic enzymes (Na et al., 
2018; Tobe & Mihara, 2018). Methionine-R-sulfoxide reductase parti-
cipates in protection against oxidative stress (Gladyshev, 2014; Kim 
et al., 2014). There is a genetic nomenclature of selenoproteins. By the 
last nomenclature, all proteins that include selenocysteine are divided 
into proteins with a known function. These are thioredoxin reductase 1, 
thioredoxin reductase 2, and thioredoxin reductase 3; glutathione pero-
xidase 1, glutathione peroxidase 2, glutathione peroxidase 3, glutathione 
peroxidase 4 and glutathione peroxidase 6; iodothyronin deiodinase 1, 
iodothyronin deiodinase 2 and iodothyronin deiodinase 3; methionine 
sulfoxide reductase B1, and selenophosphate synthetase 2. Designation 
of selenoproteins with unknown and unexplored functions by the pro-
posed nomenclature have the following abbreviations; SELENOF (sele-
noprotein F, 15-kD selenoprotein, SEP15), SELENOH (selenoprotein H, 
SELH, C11orf31), SELENOI (selenoprotein I, SELI, EPT1), SELENOK 
(selenoprotein K, SELK) , SELENOM (selenoprotein M), SELENON 
(selenoprotein N, SEPN1, SELN), SELENOO (selenoprotein O, SELO), 
SELENOP (selenoprotein P, SeP, SEPP1, SELP), SELENOS (seleno-
protein S, SELS, SEPS1, VIMP), SELENOT (selenoprotein T, SELT), 
SELENOV (selenoprotein V, SELV), and SELENOW (selenoprotein W, 
SELW, SEPW1). This system was agreed upon by the HUGO Genes 
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Commodity Committee (Gladyshev et al., 2016). This article is an attempt 
to systematize the general information of biological effects and the role of 
newly identified selenoproteins with unexplored functions in pathophy-
siological and biochemical processes. The data, published in recent years, 
were analyzed. The main task of the work is to find out promising direc-
tions in the issue of authentication of selenoproteins, which in turn will 
help determine the vectors of subsequent studies of this group of proteins.  
 
General characteristics of selenoproteins  
 
Trace element selenium (Se) is part of the polypeptide chain of 
21 natural amino acids selenocysteine (Sec), which encoded UGA codon. 
Inclusion Sec in any protein defines the affinity of the last one to seleno-
proteins. Selenoproteins have definite functions, and their synthesis is 
dependent on the specific co-factors and dietary Se. It is known that 
many pathological conditions are associated with changes in the elabo-
ration of selenoproteins and their activity. Emerging evidence points out 
that selenium deficiency or mutation and polymorphism in genes of sele-
noproteins is part of the pathogenesis of many diseases, including cardio-
vascular disorders, immune dysfunction, cancer, muscular and skeletal de-
fects, endocrine dysfunction and neurological maladies (Zoidis et al., 2018).  
Selenoproteins with unknown and unexplored functions can be 
divided into groups according to:  
Localization: 
– located in the endoplasmic reticulum membrane (Sel N, SelK, SelT); 
– located in the endoplasmic reticulum lumen (SelF, SelS, SelM, SelI); 
– located in the nucleus (SelH, SelR or methionine-R-sulfoxyd-
ructuse 1);  
– located in the cytoplasm (SelP, SelW, SelR, SelI);  
– location is unknown (SelO, SelU, SelV, Fig. 1).  
Biofunctional role:  
– regulators of oxidative stress;  
– mediators of carcinogenesis;  
– providers of insulin resistance and glucose tolerance;  
– coordinators of redox homeostasis;  
– contractors of neurodegeneration;  
– contractors of myopathy.  
 
Selenoproteins of the endoplasmic reticulum membrane  
 
Selenoprotein T (SELENOТ). Selenoprotein T (SelT) belongs to 
the thioredoxin group of selenoproteins and is regulated by a neuropep-
tide pituitary polypeptide. Almost every tissue highly expresses SelT 
during rat embryogenesis. Subsequently, its levels gradually decrease 
during maturation and adult tissues lose this selenoprotein. In the brain, 
SelT is highly produced in neuroblasts in different areas, but not deter-
mined in mature neurons, except rostral migratory streams of astrocytes 
and Bergman cells. At the same time, some endocrine tissues continue 
the expression of SelT throughout life. Among them are: the pituitary 
gland, the thyroid gland or the testis. SelT expression is detected in 
chromophilic cells of the pars distalis of the pituitary gland, but in the 
testis it was observed in spermatogenic cells and Leydig cells only. 
Additionally, partial hepatectomy exerts SelT expression in liver cells 
during regeneration. Consequently, it can be concluded that embryoge-
nesis, maturing and regeneration is characterized by SelT induction 
(Tanguy et al., 2011).  
Finding high levels of SelT in pancreatic tissue prompted some re-
searchers to study this selenoprotein in β-cell-knockout on gene SelT. 
Glucose administration shows the violation of tolerance to it in mutant 
animals and insufficiency of insulin production. Morphometric studies 
show the quantity of Langerhans islands increases while their size redu-
ces. All the above suggests that SelT is localized in the β- and δ-cells of 
the pancreas and is involved in glucose homeostasis (Prevost et al., 2013).  
Immunofluorescence and immunogold transmission electron mic-
roscopy methods revealed that SelT is produced by all endocrine cells 
of the pituitary gland. The SelT blockade in corticotropic cells encoura-
ges the development of endoplasmic reticulum (ER) stress and reduces 
the production of hormones. The study identified SelT as a subunit of 
the protein oligosaccharide transferase complex, which is indispensable 
for the ER integrity and homeostasis and promotes endocrine cells ripe-
ning and their hormone secretion (Hamieh et al., 2017).  
On the model of dopaminergic neuron cells, both silencing and ex-
cessive SelT expression affects oxidative stress and cell survival. Treat-
ment with Parkinson-inducing neurotoxins , such as 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP) or rotenone, causes SelT expression 
in the nigrostriatal pathway of wild-type mice, promoting rapid and 
heavy Parkinson-like and motor defects in SelT-deficient mice. This 
movement deterioration is associated with severe oxidative stress and 
neurodegeneration, as well as a decrease in the activity of tyrosine hyd-
roxylase and the level of dopamine in the nigrostriatal system (Bou-
khzar et al., 2016).  
Selenoprotein K (SELENOК). Today it is known that selenopro-
tein K is located in the ER and maintains a normal physiological state of 
skeletal muscle. Research has shown that Se deficiency reduces the ex-
pression of selenoprotein K and causes oxidative stress, ER stress, and 
apoptosis in chicken muscles (Fan et al., 2018).  
The development of melanoma, according to research, requires the 
expression of selenoprotein K, which is necessary for the Ca2+ flux into 
the cancerous cells. Malignant cells show a strong dependence on the 
flow of calcium. In one experiment, CRISPR/Cas9 was used to form 
the selenoprotein K deficiency in human melanoma cells. This led to a 
decrease in the Ca2+ flux and impaired function of the specialized receptor 
(IP3R), which inhibited proliferation, invasion, and cell migration. 
Consequently, the growth and metastatic potential of the tumours depend 
on the selenoprotein K synthesis in the cancer cells (Marciel et al., 2018). 
According to other data, selenoprotein K can act as a tumour sup-
pressor in human choriocarcinoma cells, negatively regulating the exp-
ression of the beta-subunit of human chorionic gonadotrophin by signa-
ling pathways ERK, p38 MAPK and Akt. All the above suggests that 
selenoprotein K may become a new target for human choriocarcinoma 
in vitro (Li et al., 2018).  
Selenoprotein K (SelK) is a membrane protein that provides anti-
oxidant protection, calcium regulation in the cell. It is a part of the 
protein degradation pathogenetic link related with the ER. The activity 
of low-speed peroxidase is regulated by SelK but within the range of 
other peroxidases. In particular, SelK reduces hydrophobic substrates, 
such as phospholipid hydroperoxides, thereby preserving membrane 
integrity. Hence, SelK can take part in membrane reconstruction. Dise-
lenide bond, as SelK demonstrated, is the first linkage in the molecule, 
which is reported for selenoprotein. The redox potential of SelK was 
much higher potential (–257 mV) than that of diselenide bonds in small 
molecules or proteins. So, SelK can be reduced by thioredoxin reductase. 
These findings are important for identification of SelK (Liu et al., 2014).  
Selenoprotein N (SELENON). SelN gene damage causes the myo-
pathy associated with this gene, characterized by muscle weakness, spi-
nal rigidity, and respiratory insufficiency. In Sel N-knockout mice under 
normal conditions, the histology of the muscles remains normal, but in 
skeletal muscle, after detecting oxidative stress, significant fine damage 
can occur. Ryanodine receptor calcium release channels (RyR) reveal a 
weaker sensibility to caffeine in SelN deficient myofibrils, displaying 
the possible role of SelN in the RyR regulation. The SelN deficiency 
also leads to the pathological development of the lungs, which is charac-
terized by expanded alveoli. This is associated with impaired of tissue 
elasticity and enhancement in quasi-static lung ductility. This conclusion 
increases the possibility that the respiratory syndrome observed in pati-
ents with SEPN1 mutations may have a primary pulmonary compo-
nent, in addition to the weakness of the respiratory muscles (Moghadas-
zadeh et al., 2013).  
Pathological changes in the SelN gene cause a group of muscle 
violations. In this case, the axial muscles are affected. Involvement of 
the SelN in Ca2+ and redox homeostasis was demonstrated in some 
studies, but how it participates in skeletal muscle physiology remains 
unclear. To find out the SelN function in vivo, a group of researchers 
created a model of SelN knockout mice. These mice are characterized 
by usual parameters of maturing and morphology, they had the appea-
rance of wild mice. Usually, SelN knockout mice display trivial defects 
only of muscle microstructure and contractile features. Forced training 
by swimming contributes to the development of specific phenotype ma-
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nifestations characterized by limited mobility and rigidity of the body as 
well as progressive curvature of the spine and an overwhelming change in 
the paravertebral muscles in SelN knockout mice. This induced phenotype 
repeats the disturbances of these muscles in patients with myopathy asso-
ciated with damage to the SEPN1 gene (Rederstorff et al., 2011).  
There are interesting results of studies in which selenoprotein N 
(SelN, SEPN1) expression was observed, depending on the deficiency 
and excess selenium in the diet. It has been shown that SelN expression 
in the cardiac muscle tissue corresponds to the dietary concentrations of 
selenium. Expression of the SelN in the heart muscle is suppressed in 
the case of selenium deficiency while with excessive consumption sti-
mulation of expression is increased compared to moderate selenium 
use. Also, levels of mRNA were studied. Selenium deficiency did not 
affect the level of SelN mRNA.  
However, SelN mRNA levels showed various expressions in diffe-
rent skeletal and cardiac muscles. Moreover, Se also regulates the levels 
of SPS1 (Selenoprotein S) and SecS mRNAs. Thus, Se regulates the 
expression of SelN gene and affects SecS and SPS1 mRNA levels. 
The consumption of Se in the diet can regulate the SelN biosynthesis by 
influencing SPS1 and SecS mRNA levels (Zhang et al., 2014).  
One study was directed to elucidate the dietary Se impact and 
mechanism of action on the contraction of uterine smooth muscle using 
SelN on a mouse model. Quantitative polymerase chain reaction analy-
sis was used to determine the levels of mRNA. Western blotting was 
performed to detect protein levels. The results of immunohistochemical 
analysis showed that Se affects the smooth muscle of the uterus. Addi-
tion of selenium increased the release of Ca2+, Ca2+-calmodulin, myosin 
lung kinease expression and myosin light chain phosphorylation, but 
did not affect reactive oxygen species (ROS). Thus Se plays an impor-
tant role with SelN in regulating smooth muscle contraction of the 
uterus (Zhou et al., 2018).  
 
Fig. 1. Localization of selenoproteins: 1 – nucleus, 2 – endoplasmic 
reticulum, SelN – selenoprotein N, SelK – selenoprotein K,  
SelT – selenoprotein T, SelF – selenoprotein F, SelS – selenoprotein S, 
SelM – selenoprotein M, SelI – selenoproten I, SelH – selenoprotein H, 
SelR – selenoproten R, SelP – selenoprotein P, SelW – selenoprotein W  
 
Selenoproteins of the endoplasmic reticulum lumen  
 
Selenoprotein M (SELENOМ). Recently it was determined that 
human hepatocellular carcinoma cells reveal excessive SelM expres-
sion. SelM expression is associated with an aggravation of malignancy. 
The authors proposed the use of SELM as a predicted marker for hepa-
tocellular carcinoma (Guerriero et al., 2014).  
Earlier, data revealed that selenoprotein M may function as thiol 
disulfide oxidoreductase, which is involved in the formation of disulfide 
bonds, and may be associated with the transport of Ca2+. However, sele-
nocysteine is present in it, and selenoprotein M can also function as a 
regulator of oxidative processes, since its decreased or increased expres-
sion, regulated by dietary selenium, changes the redox homeostasis 
(Guariniello et al., 2014). The interaction of some selenoproteins is inte-
resting. Thus, selenoprotein P (SelP-H) and mutant selenoprotein M 
(SelM) are able to bind ions of transition metal and modulate Zn2+-
mediated amyloid-β (Aβ) aggregation, production of ROS and neuroto-
xicity. Aggregation and cytotoxicity of amyloid-β (Aβ) peptide with 
transition metal ions in neuronal cells are engaged in the progression of 
Alzheimer's disease. The binding of Aβ to Zn2+ almost completely sup-
pressed the fibrillation of Aβ, which could be significantly restored by 
SelP-H and SelM, which was observed by fluorescence and electron 
transmissive microscopy. Both SelP-H and SelM inhibit Zn2+-Aβ-indu-
ced neurotoxicity and intracellular synthesis of ROS in living cells. 
Studies have shown that SelP and SelM can play a greatly role in regu-
lating the oxidation-reducing balance, as well as metallic homeostasis 
(Du et al., 2013).  
Expression of SelM is observed in the genesis of the axial skeleton 
of chickens and rodents. It was most pronounced in osteoblasts, tendons 
and bones (Grosch et al., 2013). SelM expression is also fixed in embry-
onic human kidney cells. Full-size SelM prevents aggregation of Aβ 
(β-amyloid, an appropriate Alzheimer's disease protease) by counteracting 
the oxidative stress which occurs in O-oligomer cells (Chen et al., 2013).  
Common proteins have been extracted to find out the general chan-
ges in the of all kidney proteins of transgenic rodents characterized by 
excess SelM expression. Synthesis of protein was greatly higher in 
transgenic rodents than in the control (LAP3, BAIAP2L1, CRP2, CD73, 
PDGF D, KIAA143, PRPPS-AP2, ZFP313, HSP-60, and N-WASP), 
while other proteins were diminished (ALKDH3, rMCP-3, STC-1). 
Selenium administration promoted amplified production levels of the 
five highly expressed proteins in control mice, while transgenic animals 
did not undergo changes (Goo et al., 2013).  
Changes in global protein synthesis were measured in the cerebral 
cortex in transgenic rats that expressed SelM and non-transgenic rats.  
1) Comparison of transgenic rats with non-transgenic animals 
revealed high parameters of enzyme activity for antioxidant protein in 
the cerebral cortex.  
2) Rise in activity of these enzymes stimulates depletion of the total 
antioxidant content and activity of γ-secreas in transgenic rats.  
3) Five proteins were amplified, and three of them were reduced as 
a result of excessive SelM expression.  
4) Among the five upregulated proteins, two of them were enlarged 
in both groups after addition of selenium, while the eukaryotic factor for 
initiating 4H (eIF-4H) and lactate dehydrogenase B (LDH-B) increased 
or decreased under the same conditions.  
5) Three downregulated proteins did not cause considerable chan-
ges in expression after the administration of selenium (Kim et al., 2014).  
Selenoprotein M is highly produced in the human brain, but the 
biological effect and molecular mechanism remain obscure. For verifi-
cation of SelM mechanisms of action, a mutant selenoprotein M was 
created. Then it was discovered that the new interactive SelM protein is 
galectin-1 (Gal-1). Gal-1 plays a crucial role in preventing neurodegene-
ration and promoting neuroprotection in the brain, the interaction bet-
ween SelM and Gal-1 demonstrates a new direction in the study of the 
biological function of SelM in the human brain (Qiao et al., 2013).  
Se deficiency induces a decrease in the content of glutathione pero-
xidase and the activity of catalase; elevated levels of malondialdehyde 
and reduced expression of selenoprotein RNA (mRNA) and an essen-
tial reduction in SelM protein in the brain (Huang et al., 2016).  
Selenoprotein S (SELENOS). The next selenoprotein related with 
the ER is selenoprotein S, which, by cooperation with another membrane 
protein (valozin-containing protein), provides the incorporation of sele-
noprotein K into the ER. The main evidence of this is that interaction 
between selenoprotein K and valozin-containing protein does not occur 
in cells deprived of selenoprotein S, while selenoprotein S interacts with 
valozin-containing protein, regardless of the presence or absence of 
selenoprotein K. Expression of selenoprotein S and K rises according to 
stress of the ER (Lee et al., 2015).  
The expression and location of SelS, its function and regulatory 
factors in the intact and inflammatory intestine epithelium have been 
defined. SelS was elevated in inflamed ileal tissues in patients with 
Crohn's disease. The same elevation was observed in mice models of 
enterocolitis. SelS expression was not connected with the differentiation 
555 
 Regul. Mech. Biosyst., 9(4) 
of enterocytes, but increased in response to the supplementation of sele-
nium and after correction of ER stress by an inducer of tunicamycin. 
Therefore SelS can be considered as a new marker for endoplasmic 
reticulum intestinal stress (Speckmann et al., 2014).  
To study the role of SelS in the adjustment of ER stress, the interac-
tion of selenoprotein with the membrane protein p97 on mouse neuro-
blastoma cells and human embryonic kidney cells were explored. SelS 
expression level was always enhanced when there was an ER induction 
of stress (Lee et al., 2014).  
Selenoprotein S (SelS), as one of the coordinators of the inflamma-
tory process, responds to ischemia. Recently, the exploration of transitory 
cerebral ischemia aftermaths was conducted. A decline in SelS synthe-
sis in the ischemic cell was observed 3–7 days after occlusion, but in the 
zones adjacent to hypoxic site there was an elevation in SelS expression 
corresponding to reactive astrogliosis (Liu et al., 2013).  
Cell culture has shown that SelS overexpression mitigates cytotoxi-
city and apoptosis induced by ochratoxin, as well as increases glutathione 
levels and reduces ROS, overwhelms ochratoxin-induced phosphoryla-
tion. Conversely, the SelS knockdown reduces glutathione levels, enhan-
ces the generation of ROS and ochratoxin-induced phosphorylation to 
the same extent as cytotoxicity and apoptosis (Gan et al., 2017).  
Selenoprotein S is highly expressed in skeletal muscle. The depres-
sion of the SelS gene greatly exacerbates the inflammatory profile of 
fast muscle fibers, which are generally more susceptible to degeneration 
in dystrophy (Wright et al., 2017).  
Enhanced SelS expression increases the level of nitric oxide and en-
dothelial nitric oxide synthase in endothelial cells treated by the tumour 
necrosis factor (TNF-α). A study was conducted on the human umbili-
cal vein endothelial cells culture (HUVECs). Moreover, overexpression 
of SelS keeps out the TNF-α-induced adhesion of THP-1 cells to endo-
thelial cells. Also, SelS overexpression regulates TNF-α-induced inf-
lammatory factors, including interleukin-1β, interleukin-6, interleukinin-8, 
and monocytic chemotaxic protein-1. Conversely, the SelS knockout of 
siRNA leads to an increased TNF-α-induced injury in HUVECs. Thus, 
SelS protects endothelial cells from TNF-α-induced dysfunction (Cui 
et al., 2018).  
Atherosclerotic vascular lesions may be accompanied by calcifica-
tion and differentiation of osteoblasts. Osteoblast differentiation and cal-
cification, which are induced by lipopolysaccharides (LPS) or TNF-α 
were significantly aggravated with SelS knockdown in vascular smooth 
muscle cells. The SelS knockdown also exacerbates the LPS-induced 
increase in the expression of proinflammatory cytokines TNF-α and 
interleukin-6, as well as increased expression of stress markers of ER. 
Thus, it can be assumed that SelS can suppress inflammation-induced 
calcification of smooth myocytes in vessels due to suppression of 
signaling pathways of nuclear factors and endoplasmic reticulum stress 
(Ye et al., 2018).  
Selenoprotein F (SELENOF). The selenoprotein F or 15 kDa is 
localized in the lumen of the ER and takes part in quality controlling of 
protein compaction. The RNA-induced deficiency of Sel F leads to in-
hibition of cell proliferation, whereas cell growth is restored after remo-
val of the knockdown inductor. SelF deficient cells are blocked in the 
G1 phase and show signs of ER stress. In addition, the Sel F deficiency 
leads to the displacement of the adhesive contacts of the cells to the 
periphery of the basal part, and also diminishes the migration and cellu-
lar invasive power. But all these changes are reversible and depend on 
the state of Sel F. Thus, it can be noted that Sel F plays a crucial role in 
adjustment of the G1 cell cycle phase as well as cell mobility (Bang 
et al., 2015). Selenoprotein F shows the ability to react with an enzyme 
retinol dehydrogenase that catalyzes the recovery of trans-retinol (vita-
min A). At the same time there is a blockage of this enzyme. Conseque-
ntly, the overexpression of selenoprotein F leads to a decline in the 
retinol synthesis (Tian et al., 2018).  
In the study of ultramicroscopic features in Sel F deficient cells, most 
of them exhibited the formation of membrane vesicles. Accumulation 
of bubbles modifies the shape of cells from a flat spindle to a spherical 
one. In such cells, actin fibrils are displaced to the periphery, overlap-
ping α-tubulin. These morphological alterations are invertible, and inhi-
bited by inhibitors of Rho-associated protein kinase. Sel F deficient cells 
are nonapoptotic and show a clear localization of F-actin and α-tubulin, 
as opposed to typical apoptotic blebbing cells. Thus, it can be argued 
that Sel F regulates the pathway that counteracts the RhoA / ROCK / 
MLC-dependent non-apoptotic bubble formation (Bang et al., 2015).  
 
Nuclear selenoproteins  
 
Selenoprotein H (SELENOH). Selenoprotein H is a newly identi-
fied selenoprotein, which is a nucleolar oxidoreductase. According to 
some authors, SelH regulates redox homeostasis and suppresses DNA 
damage (Cox et al., 2016). Selenoprotein H defends cells from aging 
through the effect on oxidative stress by supporting the genome (Wu 
et al., 2014). Human cells, in which the SelH expression was generated, 
were exposed to glutamate, which is known for its pathogenicity and its 
ability to cause cell death mediated by mitochondrial damage. The 
results of the study showed that cytotoxicity of glutamate is bound to an 
increase in the production of ROS, an imbalance in the dynamics of 
mitochondria and autophagy. These changes disappeared, and cellular 
integrity was restored by excessive SelH expression (Ma et al., 2017).  
It is believed that SelH is involved in redox homeostasis, as well as 
teratogenesis. Expression of SelH is elevated in tumour tissue, in undif-
ferentiated epithelial cells of the gastrointestinal tract of mice. The sup-
pression of Sel H expression by knockdown reduces cell differentiation 
and enhances proliferation and migration. Moreover, SelH knockdown 
cells are more capable of creating tumour colonies and xenografts. 
However, they show a more accelerated cell cycle. The foregoing indi-
cates SelH is the leading regulator of cell cycle progression and prevents 
uncontrolled proliferation. SelH expression is consistently dependent on 
Se, so the effect of selenium addition on cancer initiation and progressi-
on is probably due to SelH (Bertz et al., 2018).  
Selenoprotein R (SELENOR). Selenoprotein R (SelR), known as 
methionine sulfoxydreductase, is an enzyme whose role was studied in 
the SelR-knockdown epithelial cells of the eye lens, against the back-
ground of galactose-induced apoptosis. The results have shown both  
d-galactose and the SelR-gene knockdown independently induce oxida-
tive stress. But the effect of galactose on cells under the SelR knock-
down induces an even greater elevation in glucose-regulated protein 
levels, and lowers mitochondrial membrane potential, which is accom-
panied by the liberation of mitochondrial cytochrome. At the same time, 
the percentage of cells with apoptosis significantly increases. Thus, SelR 
can protect the mitochondria of lens epithelial cells against oxidative 
stress, and weaken apoptosis in these cells (Dai et al., 2016).  
The antioxidant properties of SelR are elucidated in a number of 
studies. Thus, SelR-deficient mice exhibit significantly greater sensitivity to 
acetaminophen-induced hepatocyte damage than mice without deficien-
cy. This is confirmed by necrotic lesions in the central areas of the liver 
lobes, as well as laboratory data (Kim et al., 2017; Singh et al., 2017).  
Similar changes were observed in the kidney model. The SelR 
knockdown in mouse kidney cells causes increase in cisplatin-induced 
lesions. Cisplatin induces swelling, loss of cristae and fragmentation of 
mitochondria with an increase in peroxide lipid edema, especially in 
SelR-deficient kidneys compared to kidneys with normal SelR expres-
sion (Noh et al., 2017).  
MsrB1 (or SelR) is highly expressed in immunoreactive macropha-
ges and contributes to the realization of cellular and organismal immune 
responses. MsrB1 controls immune responses by facilitating the detection 
of anti-inflammatory cytokines in macrophages. MsrB1 dependent re-
duction of oxidized methionine in proteins may constitute an unrecogni-
zed regulatory mechanism underlying immunity and inflammatory 
disease, and a new target for clinical applications (Lee et al., 2017).  
Decreased expression of MsrB3 (methionine sulfoxide reductase B3) 
promote apoptosis of cancer cells by the mitochondrial pathway and 
leads to the undoing of cancer cells. The deficiency of MsrB3 greatly 
increased the ER stress, which led to apoptosis. In addition, depletion of 
MsrB3 activates the proapoptotic Bim molecule, which is essential for 
ER-stressed apoptosis. The deficiency of MsrB3 increases the level of 
cytosolic calcium, suggesting that overexpression of MsrB3 leads to 
violations of calcium homeostasis in ER, which, as a result, causes endo-
plasmic reticulum stress. MsrB3 plays a decisive role in cancer cell apo-
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ptosis due to modulation of the stress state of ER (Kwak & Kim, 2017). 
SelR can directly interact with Aβ42 (amyloid-β, a central protein in 
Alzheimer's disease), and the interaction between SelR and Aβ42 is 
confirmed by fluorescence resonance energy transfer and co-immunopre-
cipitation. SelR is closely related to Alzheimer's disease (Wang et al., 2017).  
 
Cytoplasmic selenoproteins  
 
Selenoprotein P (SELENOP). According to published data, circu-
latory selenoprotein P (SePP) is linked to bone metabolism, but its func-
tion for bone balance is not completely known. Some researchers report 
that selenoprotein R is an important transporter of Se to the bones. Se is 
necessary for normal osteogenesis, which is confirmed by the data on 
Kashin-Beck disease, endemic Se-dependent osteoarthritis (Pietsch-
mann et al., 2014).  
One study examined the role of selenoprotein P (SelP) in recircula-
tory and ischemic alterations. The study was conducted in SelP-knockout 
mice group and in wild mice. Both groups were exposed to 30-minute 
ischemia, followed by 24-hour reperfusion. The area of myocardial 
infarction, which was evaluated by Evans coloration, was significantly 
less in the SelP-knockout mice group than in the wild mice. There was 
also a significant increase in the size of the heart in mice that excessively 
expressed SelP in the liver compared to other mice in the modeling of 
ischemia-reperfusion. These data indicate that SelP inhibition protects the 
heart against damage from ischemia-reperfusion (Chadani et al., 2018).  
Glucose administration increases the expression of genes and the 
transcriptional activity of SelP in cultured hepatocytes. Physiological 
SelP concentrations inhibit cell proliferation stimulated by vascular en-
dothelial growth factor (VEGF), tubular formation and migration in the 
endothelium of the human umbilical vein. SelP inhibits the generation and 
phosphorylation of VEGF-induced reactive oxygen species and extra-
cellular signaling regulated kinase in the endothelium of the human 
umbilical vein. Healing of the wound is disturbed in SelP expressing 
mice, while healing in SelP-knockout mice was improved (Ishikura 
et al., 2014).  
According to some researchers, selenoprotein P (SelP), a liver sec-
retory protein, causes resistance to insulin. Using sequential gene exp-
ression analysis (SAGE) and DNA chip methods, it was found that levels 
of SelP mRNA correlate with insulin resistance in humans. The intro-
duction of purified SelP disrupts insulin signaling and regulates glucose 
metabolism in both hepatocytes and myocytes. Conversely, both knock-
out and interference mediated elimination of SelP RNA improved 
system sensitivity to insulin and glucose tolerance in mice. SelP's meta-
bolic action is mediated, at least in part, by inactivation of adenosine 
monophosphate-activated protein kinase (AMPK). Thus, these results 
demonstrate the role SelP plays in the regulation of glucose metabolism 
and insulin sensitivity, suggesting that SelP may be a therapeutic target 
for type 2 diabetes (Misu et al., 2010).  
Distinct clinical investigations have proved the linkage of seleno-
protein P and insulin resistance. The researches compared serum SelP 
content of one hundred persons with different glucose insensitivity states. 
In addition, of some cardiac metabolic risk factors with SelP were eva-
luated. Among them were the intima-media thickness of the carotid 
artery, insulin resistance and high sensitivity of the C-reactive protein. 
In the serum of type 2 diabetes persons and prediabetes patients, con-
centration of SelP is significantly higher , and it is lower in patients with 
normal glucose tolerance and gradually decreasing. The same differen-
ces of SelP in blood were observed in patients with overweight and nor-
mal weight, respectively. Strong correlation was detected by Spearman's 
partial correlation analysis between serum SelP and most risk factors 
such as insulin resistance, body mass index, systolic blood pressure, he-
moglobin, glucose, aspartate aminotransferases, triglycerides, waist cir-
cumference. Consequently, glucose tolerant persons serum SelP para-
meters were increased and related to some cardiac metabolic factors such 
as atherosclerosis, insulin resistance, and inflammation (Yang et al., 2011).  
Selenoprotein P (SelP) is defined as hepatokin and promotes type 2 
diabetes insulin resistance. The depression of SelP activity may improve 
glucose metabolism. The monoclonal antibody AE2 with neutralizing 
activity against SelP was elaborated, administration of which to mice 
significantly improved glucose intolerance and insulin resistance. More-
over, the excessive administration of SelP significantly reduces the level 
of insulin in the pancreas and glucose-induced insulin secretion, which 
improves when AE2 is administered. The mapping of the epitope shows 
that AE2 recognizes the SelP region of a person adjacent to the first 
histidine-rich area. The anti-SelP polyclonal antibody improved glucose 
intolerance and insulin secretion in the diabetes model (Mita et al., 2017).  
SelP-deficient mice exhibit a "super-sustainability" phenotype after 
training, as well as enhanced production of ROS, phosphorylation of 
protein kinase and activation of the proliferative receptor with peroxide. 
However, the addition of N-acetylcysteine antioxidant reduces the pro-
duction of ROS and endurance in SelP deficient mice (Misu et al., 2017).  
There are data about the interaction of SelP with tubulin in human 
embryonic brain cells, as evidenced by the analysis of fluorescence re-
sonance energy transfer (FRET) and co-immunoprecipitation reactions 
(Du et al., 2014).  
Selenoprotein W (SELENOW). The study of selenoprotein W, in 
most cases, was performed on the model of chickens. So, it is well-
known that excess Ca2+ is present in Se deficiency, but the mechanisms 
of this phenomenon are not sufficiently studied. That is why this process 
was studied in the sample of chicken embryo and SelW knockdown 
myoblasts. It was found that Se deficiency induces typical muscle da-
mage that is accompanied by a Ca2+ disorder, oxidative stress, which 
damages the ultrastructure of the sarcoplasmic reticulum and mito-
chondria; reduction of Ca2+ channels, decrease of levels of selenium-
containing enzymes SERCA, SLC8A, CACNA1S, ORAI1, STIM1, 
TRPC1, and TRPC3. Similar changes are also observed in the case of 
modeling of SelW knockout myoblasts (Yao et al., 2016).  
Also the effect of selenoprotein W on lymphoid tissues and cultiva-
ted spleen leukocytes was studied in the inflammatory process of chic-
kens. The use of the selenogenic deficiency diet effectively reduces the 
expression of SelW mRNA and induces a considerable increase in para-
meters of COX-2 (cyclooxygenase-2), iNOS (nitric oxide synthase), 
NF-κB (nuclear factor kB), PTGE and TNF-α (tumour necrosis factor). 
Histological analysis also indicates lymphoid tissue damage in incident 
of selenium deficiency. There is an increase in the mRNA parameters of 
inflammatory factors in lymphocytes pretreated with H2O2, which is not 
registed when the culture of lymphocytes before H2O2 is treated with Se. 
Thus, the SelW inhibition leads to stimulation of the inflammatory fac-
tors genes in cultured lymphocytes of the spleen (Yu et al., 2015).  
Earlier, the effect of SelW gene blocking on viability and cell 
apoptosis, SelW mRNA expression levels when treated with H2O2 were 
studied on the pulmonary lymphocytes. The study outcomes indicated 
that cell treatment with sodium selenite vastly elevates SelW expressi-
on, and H2O2-induced cell apoptosis was significantly reduced, cell 
viability was also increased. Elimination of the SelW lymphocyte gene 
reduces cell viability, accelerates apoptosis and increases sensitivity to 
H2O2 (Yu et al., 2014).  
One study tested the ability of various selenium combinations, such 
as sodium selenite, methylseleninic acid, methyl selenocysteine, sele-
nomethionine, to increase the activity of proteins or mRNAs that are 
typical of selenium status biomarkers, namely glutathione peroxidase, 
thioredoxin reductase, selenoprotein W, selenoprotein H and selenopro-
tein F on models of various cell lines. The most effective in increasing 
all biomarkers were selenite sodium and methyl selenium cholesterol, 
while other compounds had only minor effects (Kipp et al., 2013).  
Selenoproteins with the least studied functions: V (SELENOV), I 
(SELENOI), U (SELENOU), O (SELENOO). The recently discove-
red selenoprotein U is characterized by considerable autophagosome 
formation and lysosome degradation with intact cytoskeleton in Sertoli 
cells that are exhausted or deprived of this protein. These data indicate 
that the deposition of selenoprotein U causes autophagy and reduces the 
expression of important growth factors in Sertoli cells by way of signa-
ling pathway disturbances. Generally, selenoprotein U is important for 
the survival and functioning of the Sertoli cells (Sattar et al., 2018).  
The functions of most selenoproteins are not yet identified. Among 
these, there is also selenoprotein V. SelV expression reaches its secretory 
peak during puberty, while progressive decline of expression is revealed 
in adult mice. SelV also has activity of glutathione peroxidase and thio-
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redoxin reductase (Varlamova et al., 2015). SelV (Selenoprotein V) has 
a thioredoxin-like folding and a conservative motif (CXXU, where C is 
cysteine, U-selenocysteine) in its catalytic center; it belongs to the frac-
tion of redox proteins whose participants are engaged in oxidative-re-
duction reactions. The SelV redox protein can interact with the O-linked 
N-acetylglucosamine transferease (OGT) and proteins belonging to the 
ASB family: Asb-17 and Asb-9. Specificity of SelV interactions with OGT 
and Asb-9, but not with Asb-17, is confirmed by immunoprecipitate. Ad-
ditionally, SelV mRNA expression has been shown in later stages of 
spermatogenesis, as well as during puberty and reproduction of rats 
(Varlamova et al., 2012).  
The function of SelO has not been clarified, however, there are re-
ports of the effects of SelO on chondrocyte differentiation, notably the 
increase of the mRNA levels and SelO expression when chondrogenic 
induction of ATDC5 cells. The silencing of the SelO gene leads to 
inhibition of chondrogenic differentiation, which is accompanied by the 
accumulation of several cartilaginous glycosaminoglycans and decrea-
sed activity of alkaline phosphatase in selenium deficiency cells. The in-
hibition of proliferation is also due to delay in the progression of the cell 
cycle. The deficiency of SelO stimulates the extinction of chondrocytes 
by apoptosis (Yan et al., 2016).  
The intracellular localization of SelI human selenoprotein and the 
levels of gene expression in various human tumour cell lines are deter-
mined. SelI protein was found in the nucleus, cytoplasm and endoplas-
mic reticulum, and absent in the nucleolus (Varlamova et al., 2017). For 
the convenience of perception, all the information is provided in Table 1.  
Table 1 
The general characteristic of selenoproteins (the analysis is based on publications over the last 5 years)  





Quality control of protein compaction regulates the G1 period of 
the cell cycle, as well as cellular mobility. It inhibits retinol 
dehydrogenase, which reduces the production of retinol  
It inhibits cell proliferation, causes cells blockade in the G1 
period, endopasmic reticulum stress, displacement of cells 
adhesive contacts, accumulation of membrane nonapoptotic 
vesicles 
SELENOH 
(nuclear oxide reductase) Nucleus 
Involved in redox regulation, teratogenesis (elevated in tumours), 
regulator of cell cycle progression, prevents uncontrolled 
proliferation. With excessive expression, it exhibits antioxidant 
properties. Protects DNA from damage  
Reduces cell differentiation and increase proliferation and 
migration  
SELENOI Cytoplasm, nucleus, endoplasmic reticulum Expressed in tumours of different human cell lines Unknown  
SELENOK Endoplasmic reticulum membrane 
Regulates Ca2+ flux in cancer cells, provides antioxidant 
protection, calcium regulation in the cells, and the pathway for 
degradation of the protein associated with the endoplasmic 
reticulum. Affects the physiological state of the muscles. 
Reduces phospholipid hydroperoxides (antioxidant function) 
Provides reduction of Ca2+ in cancer cells and impaired 
function of the specialized receptor (IP3R), which inhibits 





Involved in teratogenesis (increased expression in liver tumours). 
Transportation of Ca2+ affects redox homeostasis Unknown 
SELENON Endoplasmic reticulum membrane 
Participates in calcium and redox homeostasis, but mechanisms 
of regulation of skeletal, cardiac muscles, smooth muscles are 
unknown 
Demonstrates limitation of mobility and rigidity of the body, 
as well as the progressive curvature of the spine and the predo-
minant change in paravertebral muscles (signs of myopathy) 
SELENOO Unknown Affects the differentiation of chondrocytes  Stimulates inhibition of chondrocytes differentiation, delayed progression of the cell cycle, loss of chondrocytes 
SELENOP Cytoplasm, secretion by hepatocytes 
Regulation of glucose metabolism and insulin sensitivity contri-
butes to the development of insulin resistance in type 2 diabetes 
Provides improvement of systemic insulin sensitivity and 
glucose tolerance in mice, formation of the "super-sustaina-
bility" phenotype, increasing the production of reactive 
oxygen species, reducing the area of myocardial infarction  
SELENOR (methionine-
R-sulfoxid reductase) Nucleus, cytoplasm 
It can protect mitochondria from oxidative stress, and weaken 





Endoplasmic reticulum stress marker, regulator of inflammatory 
processes  
Reduces the level of glutathione, enhances the production of 
reactive oxygen species, aggravates the cytotoxicity and 
apoptosis. Exacerbates the inflammatory profile of fast 
muscle fibers, differentiation, and calcification of osteoblasts 
SELENOT Endoplasmic reticulum membrane 
It is a subunit of the protein oligosaccharide transferase complex. 
Provides the regulatory function of the endocrine glands, the 
control of glucose homeostasis. It is expressed by cells in the 
embryogenesis, during the maturation of tissues, and regeneration 
Violation of glucose tolerance, deficiency of insulin 
products, rapid and severe Parkinson-like and motor defects 
SELENOU Unknown The least studied. Can regulate the expression of important growth factors in Sertoli cells  
Considerable autophagy and lysosomal degradation with  
the intact cytoskeleton in Sertoli cells  
SELENOV Unknown 
Shows signs of belonging to the system of redox regulation, 
taking part in oxidative-reduction reactions. Maximum expres-
sion in animals is found during puberty, in adults is reduced  
Unknown 
SELENOW Cytoplasm Regulator Ca
2+releasing due to the effect on its channels in the 
sarcoplasmic reticulum of myosimplast 
Ca2+releasing, typical muscle damage, decreased cell viabi-




The identification of selenoproteins remains one of the promising 
directions of modern science. This is due, as shown by the analysis of 
recent studies, to the active involvement of this family of proteins in the 
most crucial pathophysiological processes of living systems. Some me-
chanisms of participation of selenoproteins in the oxidative balance, 
redox homeostasis, carcinogenesis, neurodegeneration and myodystro-
phic disorders have been discovered. Methods have been developed to 
demonstrate the expression of certain selenoproteins in different tissues, 
to identify the role of these proteins in various signaling pathways. 
However, many questions regarding the verification of biological func-
tions remain open. This creates interest for specialists in many areas in 




Addinsall, A. B., Wright, C. R., Andrikopoulos, S., van der Poel, C., & Stupka, N. 
(2018). Emerging roles of endoplasmic reticulum-resident selenoproteins in 
the regulation of cellular stress responses and the implications for metabolic 
disease. The Biochemical Journal, 475(6), 1037–1057.  
Bang, J., Huh, J. H., Na, J. W., Lu, Q., Carlson, B. A., Tobe, R., Tsuji, P. A., 
Gladyshev, V. N., Hatfield, D. L., & Lee, B. J. (2015). Cell proliferation and 
558 
 Regul. Mech. Biosyst., 9(4) 
motility are inhibited by G1 phase arrest in 15-kDa selenoprotein-deficient 
chang liver cells. Molecules and Cells, 38(5), 457–465.  
Bang, J., Jang, M., Huh, J. H., Na, J. W., Shim, M., Carlson, B. A., Tobe, R., Tsuji, 
P. A., Gladyshev, V. N., Hatfield, D. L., & Lee, B. J. (2015). Deficiency of 
the 15-kDa selenoprotein led to cytoskeleton remodeling and non-apoptotic 
membrane blebbing through a RhoA/ROCK pathway. Biochemical and 
Biophysical Research Communications, 456(4), 884–890.  
Bertz, M., Kühn, K., Koeberle, S. C., Müller, M. F., Hoelzer, D., Thies, K., Deu-
bel, S., Thierbach, R., & Kipp, A. P. (2018). Selenoprotein H controls cell 
cycle progression and proliferation of human colorectal cancer cells. Free 
Radical Biology and Medicine, pii: S0891-5849(18)30020-0.  
Bobba, A., Casalino, E., Petragallo, V. A., & Atlante, A. (2014). Thioredoxin/thio-
redoxin reductase system involvement in cerebellar granule cell apoptosis. 
Apoptosis, 19(10), 1497–1508.  
Boukhzar, L., Hamieh, A., Cartier, D., Tanguy, Y., Alsharif, I., Castex, M., Arabo, 
A., El Hajji, S., Bonnet, J. J., Errami, M., Falluel-Morel, A., Chagraoui, A., 
Lihrmann, I., & Anouar, Y. (2016). Selenoprotein T exerts an essential 
oxidoreductase activity that protects dopaminergic neurons in mouse models 
of Parkinson's disease. Antioxidants and Redox Signaling, 24(11), 557–574.  
Brigelius-Flohé, R. (2015). The evolving versatility of selenium in biology. Anti-
oxidants and Redox Signaling, 23(10), 757–760.  
Burk, R. F., Hill, K. E., Motley, A. K., Winfrey, V. P., Kurokawa, S., Mitchell, S. L., 
& Zhang, W. (2014). Selenoprotein P and apolipoprotein E receptor-2 
interact at the blood-brain barrier and also within the brain to maintain an 
essential selenium pool that protects against neurodegeneration. FASEB 
Journal, 28(8), 3579–3588.  
Chadani, H., Usui, S., Inoue, O., Kusayama, T., Takashima, S. I., Kato, T., Murai, 
H., Furusho, H., Nomura, A., Misu, H., Takamura, T., Kaneko, S., & Taka-
mura, M. (2018). Endogenous selenoprotein P, a liver-derived secretory 
protein, mediates myocardial ischemia/reperfusion injury in mice. Internatio-
nal Journal of Molecular Science, 19(3), e878.  
Chen, P., Wang, R. R., Ma, X. J., Liu, Q., & Ni, J. Z. (2013). Different forms of 
selenoprotein M differentially affect Aβ aggregation and ROS generation. 
International Journal of Molecular Sciences, 14(3), 4385–4399.  
Cox, A. G., Tsomides, A., Kim, A.J., Saunders, D., Hwang, K. L., Evason, K. J., 
Heidel, J., Brown, K. K., Yuan, M., Lien, E. C., Lee, B. C., Nissim, S., 
Dickinson, B., Chhangawala, S., Chang, C. J., Asara, J. M., Houvras, Y., 
Gladyshev,V. N., & Goessling, W. (2016). Selenoprotein H is an essential 
regulator of redox homeostasis that cooperates with p53 in development and 
tumorigenesis. Proceedings of the National Academy of Science of the United 
States of America, 113(38), e5562–e5571.  
Cui, S., Men, L., Li, Y., Zhong, Y., Yu, S., Li, F., & Du, J. (2018). Selenoprotein S 
attenuates tumor necrosis factor-α-induced dysfunction in endothelial cells. 
Mediators of Inflammation, 2018, 1625414.  
Dai, J., Liu, H., Zhou, J., & Huang, K. (2016). Selenoprotein R protects human 
lens epithelial cells against D-galactose-induced apoptosis by regulating 
oxidative stress and endoplasmic reticulum stress. International Journal of 
Molecular Sciences, 17(2), 231.  
Du, X., Li, H., Wang, Z., Qiu, S., Liu, Q., & Ni, J. (2013). Selenoprotein P and 
selenoprotein M block Zn2+-mediated Aβ42 aggregation and toxicity. 
Metallomics, 5(7), 861–870.  
Du, X., Qiu, S., Wang, Z., Wang, R., Wang, C., Tian, J., & Liu, Q. (2014). Direct 
interaction between selenoprotein P and tubulin. International Journal of 
Molecular Sciences, 15(6), 10199–10214.  
Fan, R. F., Cao, C. Y., Chen, M. H., Shi, Q. X., & Xu, S. W. (2018). Gga-let-7f-3p 
promotes apoptosis in selenium deficiency-induced skeletal muscle by 
targeting selenoprotein K. Metallmics, 7, 869–1030.  
Gan, F., Hu, Z., Zhou, Y., & Huang, K. (2017). Overexpression and low 
expression of selenoprotein S impact ochratoxin A-induced porcine cytotoxi-
city and apoptosis in vitro. Journal of Agricultural and Food Chemistry, 
65(32), 6972–6981.  
Gladyshev, V. N. (2014). Selenium and methionine sulfoxide reduction. Free 
Radical Biology and Medicine, 75(1), S8–S9.  
Gladyshev, V. N., Arnér, E. S., Berry, M. J., Brigelius-Flohé, R., Bruford, E. A., Burk, 
R. F., Carlson, B. A., Castellano, S., Chavatte, L., Conrad, M., Copeland, 
P. R., Diamond, A. M., Driscoll, D. M., Ferreiro, A., Flohé, L., Green, F. R., 
Guigó, R., Handy, D. E., Hatfield, D. L., Hesketh, J., Hoffmann, P. R., Holm-
gren, A., Hondal, R. J., Howard, M. T., Huang, K., Kim, H. Y., Kim, I. Y., 
Köhrle, J., Krol, A., Kryukov, G. V., Lee, B. J., Lee, B. C., Lei, X. G., Liu, 
Q., Lescure, A., Lobanov, A. V., Loscalzo, J., Maiorino, M., Mariotti, M., 
Sandeep, P. K., Rayman, M. P., Rozovsky, S., Salinas, G., Schmidt, E. E., 
Schomburg, L., Schweizer, U., Simonović, M., Sunde, R. A., Tsuji, P. A., 
Tweedie, S., Ursini, F., Whanger, P. D., & Zhang, Y. (2016). Selenoprotein 
gene nomenclature. The Journal of Biological Chemistry, 291(46), 24036–
24040.  
Goo, J. S., Kim, Y. N., Choi, K. M., Hwang, I. S., Kim, J. E., Lee, Y. J., Kwak, M. H., 
Shim, S. B., Jee, S. W., Lim, C. J., Seong, J. K., & Hwang, D. Y. (2013). 
Proteomic analysis of kidneys from selenoprotein M transgenic rats in res-
ponse to increased bioability of selenium. Clinical Proteomics, 10(1), 10.  
Grosch, M., Fuchs, J., Bösl, M., Winterpacht, A., & Tagariello, A. (2013). Seleno-
protein M is expressed during bone development. EXCLI Journal, 12, 967–979.  
Guariniello, S., Colonna, G., Raucci, R., Costantini, M., Di Bernardo, G., Bergan-
tino, F., Castello, G., & Costantini, S. (2014). Structure-function relationship 
and evolutionary history of the human selenoprotein M (SelM) found over-
expressed in hepatocellular carcinoma. Biochimica et Biophysica Acta, 
1844(2), 447–456.  
Guerriero, E., Accardo, M., Capone, F., Colonna, G., Castello, G., & Costantini, S. 
(2014). Assessment of the Selenoprotein M (SELM) over-expression on hu-
man hepatocellular carcinoma tissues by immunohistochemistry. European 
Journal of Histochemistry, 58(4), 287–290.  
Hamieh, A., Cartier, D., Abid, H., Calas, A., Burel, C., Bucharles, C., Jehan, C., 
Grumolato, L., Landry, M., Lerouge, P., Anouar, Y., & Lihrmann, I. (2017). 
Selenoprotein T is a novel OST subunit that regulates UPR signaling and 
hormone secretion. EMBO Reports, 18(11), 1935–1946.  
Hernandez, A., & Stohn, J. P. (2018). The type 3 deiodinase: Epigenetic control of 
brain thyroid hormone action and neurological function. International Journal 
of Molecular Sciences, 19(6), e1804.  
Huang, J. Q., Ren, F. Z., Jiang, Y. Y., & Lei, X. (2016). Characterization of sele-
noprotein M and its response to selenium deficiency in chicken brain. Biolo-
gical Trace Element Resesrch, 170(2), 449–458.  
Ishikura, K., Misu, H., Kumazaki, M., Takayama, H., Matsuzawa-Nagata, N., Ta-
jima, N., Chikamoto, K., Lan, F., Ando, H., Ota, T., Sakurai, M., Takeshita, Y., 
Kato, K., Fujimura, A., Miyamoto, K., Saito, Y., Kameo, S., Okamoto, Y., 
Takuwa, Y., Takahashi, K., Kidoya, H., Takakura, N., Kaneko, S., & Taka-
mura, T. (2014). Selenoprotein P as a diabetes-associated hepatokine that 
impairs angiogenesis by inducing VEGF resistance in vascular endothelial 
cells. Diabetologia, 57(9), 1968–1976.  
Kim, J. Y., Kim, Y., Kwak, G. H., Oh, S. Y., & Kim, H. Y. (2014). Over-expres-
sion of methionine sulfoxide reductase A in the endoplasmic reticulum 
increases resistance to oxidative and ER stresses. Acta Biochimica and 
Biophysica Sinica, 46(5), 415–419.  
Kim, K. Y., Kwak, G. H., Singh, M. P., Gladyshev, V. N., & Kim, H. Y. (2017). 
Selenoprotein MsrB1 deficiency exacerbates acetaminophen-induced hepa-
totoxicity via increased oxidative damage. Archives of Biochemistry and 
Biophisics, 634, 69–75.  
Kim, Y., Goo, J. S., Kim, I. Y., Kim, J. E., Kwak, M. H., Go, J., Shim, S., Hong, J. T., 
Hwang, D. Y., & Seong, J. K. (2014). Identification of the responsible prote-
ins for increased selenium bioavailability in the brain of transgenic rats over-
expressing selenoprotein M. International Journal of Molecular Medicine, 
34(6), 1688–1698.  
Kipp, A. P., Frombach, J., Deubel, S., & Brigelius-Flohé, R. (2013). Selenoprotein 
W as biomarker for the efficacy of selenium compounds to act as source for 
selenoprotein biosynthesis. Methods in Enzymology, 527, 87–112.  
Kwak, G. H., & Kim, H. Y. (2017). MsrB3 deficiency induces cancer cell apopto-
sis through p53-independent and ER stress-dependent pathways. Archives of 
Biochemistry and Biophysics, 621, 1–5.  
Lee, B. C., Lee, S. G., Choo, M. K., Kim, J. H., Lee, H. M., Kim, S., Fomenko, D. E., 
Kim, H. Y., Park, J. M., & Gladyshev, V. N. (2017). Selenoprotein MsrB1 
promotes anti-inflammatory cytokine gene expression in macrophages and 
controls immune response in vivo. Scientific Reports, 7(1), 5119.  
Lee, J. H., Kwon, J. H., Jeon, Y. H., Ko, K. Y., Lee, S. R., & Kim, I. Y. (2014). 
Pro178 and Pro183 of selenoprotein S are essential residues for interaction 
with p97(VCP) during endoplasmic reticulum-associated degradation. The 
Journal of Biological Chemistry, 289(20), 13758–13768.  
Lee, J. H., Park, K. J., Jang, J. K., Jeon, Y. H., Ko, K. Y., Kwon, J. H., Lee, S. R., 
& Kim, I. Y. (2015). Selenoprotein S-dependent selenoprotein K binding to 
p97(VCP) protein is essential for endoplasmic reticulum-associated degrada-
tion. The Journal of Biological Chemistry, 290(50), 29941–29952.  
Li, M., Cheng, W., Nie, T., Lai, H., Hu, X., Luo, J., Li, F., & Li, H. (2018). Sele-
noprotein K mediates the proliferation, migration, and invasion of human 
choriocarcinoma cells by negatively regulating human chorionic gonadotropin 
expression via ERK, p38 MAPK, and akt signaling pathway. Biological 
trace element research, 184(1), 47–59.  
Liu, J., Zhang, Z., & Rozovsky, S. (2014). Selenoprotein K form an intermolecu-
lar diselenide bond with unusually high redox potential. FEBS Letters, 
588(18), 3311–3321.  
Liu, L. X., Zhou, X. Y., Li, C. S., Liu, L. Q., Huang, S. Y., & Zhou, S. N. (2013). 
Selenoprotein S expression in the rat brain following focal cerebral ischemia. 
Neurological Sciences: Official Journal of the Italian Neurological Society 
and of the Italian Society of Clinical Neurophysiology, 34(9), 1671–1678.  
Ma, Y. M., Guo, Y. Z., Ibeanu, G., Wang, L. Y., Dong, J. D., Wang, J., Jing, L., 
Zhang, J. Z., & Li, P. A. (2017). Overexpression of selenoprotein H prevents 
mitochondrial dynamic imbalance induced by glutamate exposure. Interna-
tional Journal of Biological Sciences, 13(11), 1458–1469.  
559 
 Regul. Mech. Biosyst., 9(4) 
Marciel, M. P., Khadka, V. S., Deng, Y., Kilicaslan, P., Pham, A., Bertino, P., Lee, K., 
Chen, S., Glibetic, N., Hoffmann, F. W., Matter, M. L., & Hoffmann, P. R. 
(2018). Selenoprotein K deficiency inhibits melanoma by reducing calcium flux 
required for tumor growth and metastasis. Oncotarget, 9(17), 13407–13422.  
Misu, H., Takamura, T., Takayama, H., Hayashi, H., Matsuzawa-Nagata, N., Kurita, 
S., Ishikura, K., Ando, H., Takeshita, Y., Ota, T., Sakurai, M., Yamashita, T., 
Mizukoshi, E., Yamashita, T., Honda, M., Miyamoto, K., Kubota, T., Kubota, 
N., Kadowaki, T., Kim, H. J., Lee, I. K., Minokoshi, Y., Saito, Y., Takahashi, K., 
Yamada, Y., Takakura, N., & Kaneko, S. (2010). A liver-derived secretory 
protein, selenoprotein P, causes insulin resistance. Cell Metabolism, 12(5), 
483–495.  
Misu, H., Takayama, H., Saito, Y., Mita, Y., Kikuchi, A., Ishii, K. A., Chikamoto, K., 
Kanamori, T., Tajima, N., Lan, F., Takeshita, Y., Honda, M., Tanaka, M., Kato, 
S., Matsuyama, N., Yoshioka, Y., Iwayama, K., Tokuyama, K., Akazawa, N., 
Maeda, S., Takekoshi, K., Matsugo, S., Noguchi, N., Kaneko, S., & Taka-
mura, T. (2017). Deficiency of the hepatokine selenoprotein P increases res-
ponsiveness to exercise in mice through upregulation of reactive oxygen 
species and AMP-activated protein kinase in muscle. Nature Medicine, 
23(4), 508–516.  
Mita, Y., Nakayama, K., Inari, S., Nishito, Y., Yoshioka, Y., Sakai, N., Sotani, K., 
Nagamura, T., Kuzuhara, Y., Inagaki, K., Iwasaki, M., Misu, H., Ikegawa, M., 
Takamura, T., Noguchi, N., & Saito, Y. (2017). Selenoprotein P-neutralizing 
antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes 
mouse models. Nature Communications, 8(1), 1658.  
Moghadaszadeh, B., Rider, B. E., Lawlor, M. W., Childers, M. K., Grange, R. W., 
Gupta, K., Boukedes, S. S., Owen, C. A., & Beggs, A. H. (2013). Selenopro-
tein N deficiency in mice is associated with abnormal lung development. 
FASEB Journal, 27(4), 1585–1599.  
Na, J., Jung, J., Bang, J., Lu, Q., Carlson, B. A., Guo, X., Gladyshev, V. N., Kim, J., 
Hatfield, D. L., & Lee, B. J. (2018). Selenophosphate synthetase 1 and its role in 
redox homeostasis, defense and proliferation. Free Radical Biology and 
Medicine, 127, 190–197.  
Noh, M. R., Kim, K. Y., Han, S. J., Kim, J. I., Kim, H. Y., & Park, K. M. (2017). 
Methionine sulfoxide reductase A deficiency exacerbates cisplatin-induced 
nephrotoxicity via increased mitochondrial damage and renal cell death. 
Antioxidants and Redox Signaling, 27(11), 727–741.  
Pietschmann, N., Rijntjes, E., Hoeg, A., Stoedter, M., Schweizer, U., Seemann, P., 
& Schomburg, L. (2014). Selenoprotein P is the essential selenium transpor-
ter for bones. Metallomics: Integrated Biometal Science, 6(5), 1043–1049.  
Pitts, M. W., Byrns, C. N., Ogawa-Wong, A. N., Kremer, P., & Berry, M. J. (2014). 
Selenoproteins in nervous system development and function. Biological 
Trace Element Research, 161(3), 231–245.  
Prevost, G., Arabo, A., Jian, L., Quelennec, E., Cartier, D., Hassan, S., Falluel-
Morel, A., Tanguy, Y., Gargani, S., Lihrmann, I., Kerr-Conte, J., Lefebvre, H., 
Pattou, F., & Anouar, Y. (2013). The PACAP-regulated gene selenoprotein T is 
abundantly expressed in mouse and human β-cells and its targeted inactiva-
tion impairs glucose tolerance. Endocrinology, 154(10), 3796–3806.  
Qiao, X., Tian, J., Chen, P., Wang, C., Ni, J., & Liu, Q. (2013). Galectin-1 is an 
interactive protein of selenoprotein M in the brain. International Journal of 
Molecular Sciences, 14(11), 22233–22245.  
Rederstorff, M., Castets, P., Arbogast, S., Lainé, J., Vassilopoulos, S., Beuvin, M., 
Dubourg, O., Vignaud, A., Ferry, A., Krol, A., Allamand, V., Guicheney, P., 
Ferreiro, A., & Lescure, A. (2011). Increased muscle stress-sensitivity indu-
ced by selenoprotein N inactivation in mouse: A mammalian model for 
SEPN1-related myopathy. PLoS One, 6(8), 1–13.  
Sattar, H., Yang, J., Zhao, X., Cai, J., Liu, Q., Ishfaq, M., Yang, Z., Chen, M., 
Zhang, Z., & Xu, S. (2018). Selenoprotein-U (SelU) knockdown triggers 
autophagy through PI3K-Akt-mTOR pathway inhibition in rooster Sertoli 
cells. Metallmics, 10(7), 929–940.  
Short, S. P., & Williams, C. S. (2017). Selenoproteins in tumorogenesis and cancer 
progression. Advances in Cancer Research, 136, 49–83.  
Singh, M. P., Kim, K. Y., & Kim, H. Y. (2017). Methionine sulfoxide reductase A 
deficiency exacerbates acute liver injury induced by acetaminophen. Bioche-
mical and Biophysical Research Communications, 484(1), 189–194.  
Speckmann, B., Gerloff, K., Simms, L., Oancea, I., Shi, W., McGuckin, M. A., 
Radford-Smith, G., Khanna, K. K., Speckmann, B., Gerloff, K., Simms, L., 
Oancea, I., Shi, W., McGuckin, M. A., Radford-Smith, G., & Khanna, K. K. 
(2014). Selenoprotein S is a marker but not a regulator of endoplasmic reticu-
lum stress in intestinal epithelial cells. Free Radical Biology and Medicine, 
67, 265–277.  
Tanguy, Y., Falluel-Morel, A., Arthaud, S., Boukhzar, L., Manecka, D. L., Chagra-
oui, A., Prevost, G., Elias, S., Dorval-Coiffec, I., Lesage, J., Vieau, D., Lihr-
mann, I., Jégou, B., & Anouar, Y. (2011). The PACAP-regulated gene sele-
noprotein T is highly induced in nervous, endocrine, and metabolic tissues 
during ontogenetic and regenerative processes. Endocrinology, 152(11), 
4322–4335.  
Tian, J., Liu, J., Li, J., Zheng, J., Chen, L., Wang, Y., Liu, Q., & Ni, J. (2018). The 
interaction of selenoprotein F (SELENOF) with retinol dehydrogenase 11 
(RDH11) implied a role of SELENOF in vitamin A metabolism. Nutrition 
and Metabolism, 15(7), 1–9.  
Tobe, R., & Mihara, H. (2018). Delivery of selenium to selenophosphate synthetase 
for selenoprotein biosynthesis. Biochimica and Biophysica Acta, 1, pii: 
S0304-4165(18)30155-7.  
Varlamova, E. G., & Novoselov, V. I. (2012). Poisk partnjorov novogo selenovogo 
belka mlekopitajushhih (SELV) i jekspressiya ego mRNK v processe onto-
geneza i spermatogeneza [The search of partners of a new mammalian 
selenium-containing protein V (SelV) and expression it's mRNA during 
ontogenesis and spermatogenesis]. Moleculiarnaia Biologiia, 46(2), 276–284 
(in Russian).  
Varlamova, E. G., Goltyaev, M. V., Novoselov, V. I., & Fesenko, E. E. (2017). 
Cloning, intracellular localization, and expression of the mammalian seleno-
cysteine-containing protein SELENOI (SelI) in tumor cell lines. Doclady 
Biochemistry and Biophysics, 476(1), 320–322.  
Varlamova, E. G., Novoselov, S. V., & Novoselov, V. I. (2015). Klonirovanie КDNK, 
jekspressiya i opredelenie substratnoj spetcifichnosti selenosoderzhashhego 
belka myshy SELV(SELENOPROTEIN V) [cDNA cloning, expression 
and determination of substrate specificity of mice selenocysteine-containing 
protein SelV (Selenoprotein V)]. Moleculiarnaia Biologiia, 49(5), 785–789 
(in Russian).  
Wang, C., Chen, P., He, X., Peng, Z., Chen, S., Zhang, R., Cheng, J., & Liu, Q. 
(2017). Direct interaction between selenoprotein R and Aβ42. Biochemical 
and Biophysical Research Communications, 489(4), 509–514.  
Wright, C. R., Allsopp, G. L., Addinsall, A. B., McRae, N. L., Andrikopoulos, S., 
& Stupka, N. (2017). A reduction in selenoprotein S amplifies the inflame-
matory profile of fast-twitch skeletal muscle in the mdx dystrophic mouse. 
Mediators of Inflammation, 2017, 7043429.  
Wrobel, J. K., Power, R., & Toborek, M. (2016). Biological activity of selenium: 
Revisited. IUBMB Life, 68(2), 97–105.  
Wu, R. T., Cao, L., Chen, B. P., & Cheng, W. H. (2014). Selenoprotein H suppresses 
cellular senescence through genome maintenance and redox regulation. The 
Journal of Biological Chemistry, 289(49), 34378–34388.  
Yan, J., Fei, Y., Han, Y., & Lu, S. (2016). Selenoprotein O deficiencies suppress 
chondrogenic differentiation of ATDC5 cells. Cell Biology International, 
40(10), 1033–1040.  
Yang, S. J., Hwang, S. Y., Choi, H. Y., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., 
Baik, S. H., Choi, D. S., & Choi, K. M. (2011). Serum selenoprotein P levels 
in patients with type 2 diabetes and prediabetes: Implications for insulin 
resistance, inflammation, and atherosclerosis. The Journal of Clinical Endo-
crinology and Metabolism, 96(8), 1325–1329.  
Yao, H., Fan, R., Zhao, X., Zhao, W., Liu,W., Yang, J., Sattar, H., Zhao, J., 
Zhang, Z., & Xu, S. (2016). Selenoprotein W redox-regulated Ca2+ channels 
correlate with selenium deficiency-induced muscles Ca2+ leak. Oncotarget, 
7(36), 57618–57632.  
Ye, Y., Bian, W., Fu, F., Hu, J., & Liu, H. (2018). Selenoprotein S inhibits inflam-
mation-induced vascular smooth muscle cell calcification. Journal of Biolo-
gical Inorganic Chemistry, 23(5), 739–751.  
Yu, D., Zhang, Z. W., Yao, H. D., Li, S., & Xu, S. W. (2014). Antioxidative role 
of selenoprotein W in oxidant-induced chicken splenic lymphocyte death. 
Biometals, 27(2), 277–291.  
Yu, D., Zhang, Z., Yao, H., Li, S., & Xu, S. W. (2015). The role of selenoprotein 
W in inflammatory injury in chicken immune tissues and cultured splenic 
lymphocyte. Biometals, 28(1), 75–87.  
Zachara, B. A. (2015). Selenium and selenium-dependent antioxidants in chronic 
kidney disease. Advances in Clinical Chemistry, 68, 131–151.  
Zhang, J. L., Zhang, Z. W., Shan, A. S., & Xu, S. W. (2014). Effects of dietary 
selenium deficiency or excess on gene expression of selenoprotein N in 
chicken muscle tissues. Biological Trace Element Research, 157(3), 234–241.  
Zhou, J., Li, C., Gu, G., Wang, Q., & Guo, M. (2018). Selenoprotein N was 
required for the regulation of selenium on the uterine smooth muscle contrac-
tion in mice. Biological Trace Element Research, 183(1), 138–146.  
Zoidis, E., Seremelis, I., Kontopoulos, N., & Danezis, G. P. (2018). Selenium-de-
pendent antioxidant enzymes: Actions and properties of selenoproteins. 
Antioxidants, 7(5), 66.  
 
560 
